| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 64576 |
Glcα1-4[Glcα1-4]3Glc-O-(CH2)3-NH-Biotin ，与生物素连接的麦芽糖DP5(接头-BT B) |
183 |
kx |
2024-12-13 |
| 64577 |
带有DBCO的麦芽三糖， Glcα1-4Glcα1-4Glc-O-(CH2)3-NH-DBCO |
86 |
kx |
2024-12-13 |
| 64578 |
Glcβ1-4[Glcβ1-4]3Glc-O-(CH2)3-NH2.HCl ，具有游离末端胺(接头-NH2 A)的纤维二糖 |
81 |
kx |
2024-12-13 |
| 64579 |
Glcβ1-4[Glcβ1-4]2Glc-O-(CH2)3-NH-DBCO ，含DBCO的纤维四糖(接头-DBCO A) |
115 |
kx |
2024-12-13 |
| 64580 |
DOTA-CH2-Ph-azide(HCl salt),DOTA螯合剂 |
115 |
h |
2024-12-13 |
| 64581 |
Glcβ1-4Glc-O-(CH2)3-NH-DBCO ， 含DBCO的纤维二糖(接头-DBCO A) |
107 |
kx |
2024-12-13 |
| 64582 |
DOTA-DBCO双功能螯合剂 |
88 |
h |
2024-12-13 |
| 64583 |
Glcβ1-4Glcβ1-4Glc-O-(CH2)3-NH-DBCO ， 含DBCO的纤维三糖(接头-DBCO A) |
95 |
kx |
2024-12-13 |
| 64584 |
DOTA-(COOt-Bu)3-NHS,CAS:819869-77-7 |
62 |
h |
2024-12-13 |
| 64585 |
GlcNAcβ1-3Gal与生物素和硬脂酸链相连(接头-BT-STEA A) |
87 |
kx |
2024-12-13 |
| 64586 |
棕榈酸-酮缩硫醇-羧酸，C16-TK-COOH |
92 |
wyh |
2024-12-13 |
| 64587 |
DOTA-(COOt-Bu)3-C2-NH2,CAS:173308-19-5 |
78 |
h |
2024-12-13 |
| 64588 |
Methyltetrazine-PEG5-CO-piperazine-C3-Mal的应用领域 |
86 |
kx |
2024-12-13 |
| 64589 |
DO-(CH2COOt-Bu)2,环状多胺多羧类配体,CAS：162148-48-3 |
92 |
h |
2024-12-13 |
| 64590 |
4,7,10-TRI-(T-BUTYLOXYCARBONYLMETHYL) |
62 |
h |
2024-12-13 |
| 64591 |
carboxymethyl-dextran-A2-gadolinium-DOTA |
69 |
h |
2024-12-13 |
| 64592 |
Tat-DOTA,DOTA-TAT(48-60),DOTA偶联细胞穿膜肽TAT |
129 |
h |
2024-12-13 |
| 64593 |
Cl-C6-PEG4-NHCO-C3-NHS，氯-C6--四聚乙二醇-酰胺-C3-琥珀酰亚胺酯 |
104 |
kx |
2024-12-13 |
| 64594 |
dysprosium-DOTA-PAMAM |
78 |
h |
2024-12-13 |
| 64595 |
Cl-C6-PEG3-NHCO-C3-NHS，氯-C6--三聚乙二醇-酰胺-C3-琥珀酰亚胺酯 |
126 |
kx |
2024-12-13 |
| 64596 |
Y-DOTA-TOC,CAS：293295-66-6 |
83 |
h |
2024-12-13 |
| 64597 |
DOTA-MAL-Cys39-exendin-4 |
118 |
h |
2024-12-13 |
| 64598 |
DO3A叔丁酯,CAS: 122555-91-3 |
212 |
h |
2024-12-13 |
| 64599 |
1202761-21-4，Biotinyl-NH-PEG3-C3-amido-C3-COOH |
113 |
kx |
2024-12-13 |
| 64600 |
(m-PEG4)2-C-C3-Br |
100 |
kx |
2024-12-13 |
| 64601 |
1,1,4,4,7,7-六(1,1-二甲基乙基)10,10-[(5-硝基-1,3-苯基)双(亚甲基)]双[1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸酯 |
155 |
h |
2024-12-13 |
| 64602 |
二乙酰氧二辛基锡盐,CAS:17586-94-6 |
123 |
h |
2024-12-13 |
| 64603 |
二苯基环辛炔-聚乙二醇-大环配体 |
92 |
h |
2024-12-13 |
| 64604 |
Azide-PEG11-CH2CH2CH2-COOtBu，叠氮-十一聚乙二醇-C3-叔丁酯 |
114 |
kx |
2024-12-13 |
| 64605 |
(S)-4-(4-(3-((4-((2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL) |
122 |
h |
2024-12-13 |
| 64606 |
DOTA四乙酸酯,CAS: 825625-07-8 |
177 |
h |
2024-12-13 |
| 64607 |
Boc-NH-PEG7-C3-acid，氨基叔丁酯-七聚乙二醇-C3-酸 |
78 |
kx |
2024-12-13 |
| 64608 |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid |
101 |
h |
2024-12-13 |
| 64609 |
2731015-03-3，Boc-NH-PEG1-C3-acid，氨基叔丁酯-一聚乙二醇-C3-酸 |
100 |
kx |
2024-12-13 |
| 64610 |
Azide-PEG6-CH2CH2CH2-COOtBu，叠氮-六聚乙二醇-C3-叔丁酯 |
79 |
kx |
2024-12-13 |
| 64611 |
APN-C3-PEG5-acid， APN-C3-五聚乙二醇-羧酸 |
81 |
kx |
2024-12-13 |
| 64612 |
Pomalidomide-C3-NH2 hydrochloride的主要结构与功能基团 |
96 |
kx |
2024-12-13 |
| 64613 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, α-(2-carboxyethyl)-, 1,4,7,10-tetrakis(1,1-dimethylethyl)ester,(αR)- |
116 |
h |
2024-12-13 |
| 64614 |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid |
78 |
h |
2024-12-13 |
| 64615 |
Azide-C3-Iodoacetamide的应用领域 |
76 |
kx |
2024-12-13 |
| 64616 |
CAS: 1161883-51-7，Propargyl-PEG5-CH2CO2-NHS |
107 |
WYQ |
2024-12-13 |
| 64617 |
CAS: 1429934-37-1，Propargyl-PEG5-CH2CO2H |
80 |
WYQ |
2024-12-13 |
| 64618 |
CAS：1610950-41-8,DOTA-甲基四嗪 |
81 |
h |
2024-12-13 |
| 64619 |
CAS: 1694731-93-5，Propargyl-PEG4-CH2CO2H |
65 |
WYQ |
2024-12-13 |
| 64620 |
CAS: 141282-35-1，Amino-PEG5-CH2CO2H（氨基-五聚乙二醇-乙酸） |
79 |
WYQ |
2024-12-13 |
齐岳微信公众号
官方微信
库存查询